IBAB Ion Beam Applications SA

IBA signs contract for the first end-to-end Rhodotron® DUO solution for multi-purpose irradiation in Taiwan

IBA signs contract for the first end-to-end Rhodotron® DUO solution for multi-purpose irradiation in Taiwan
EN
06/10/2020

Underlying

IBABIon Beam Applications SA

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Ion Beam Applications SA

 PRESS RELEASE
Free
IBAB Ion Beam Applic...

IBA – TRANSPARENCY NOTIFICATION

IBA – TRANSPARENCY NOTIFICATION (Article 14, paragraph 1 of the law of 2 May 2007 on the disclosure of major holdings) Louvain-la-Neuve, Belgium, November 12th, 2025 06:00 PM Summary of the notification IBA SA (Ion Beam Applications SA), the world’s leading provider of proton therapy solutions for the treatment of cancer, announces that it has to issue a transparency notification, in accordance with Article 14, al. 1 of the Transparency Law of May 2, 2007 on disclosure of major holdings, further to the notification received on November 7th, 2025. In its notification, IBA SA indicated...

1h / 27m 1 EN
 PRESS RELEASE
Free
IBAB Ion Beam Applic...

IBA SA – NOTIFICATION TRANSPARENCE

IBA SA – NOTIFICATION TRANSPARENCE (article 14, alinéa 1er de la loi du 2 mai 2007 relative à la publicité des participations importantes) Louvain-la-Neuve, Belgique, le 12 novembre 2025, 18:00 Résumé de la notification IBA SA (Ion Beam Applications SA), le premier fournisseur mondial de solutions de protonthérapie pour le traitement du cancer, annonce devoir effectuer une notification en matière de transparence conformément à l'article 14, alinéa 1er de la loi du 2 mai 2007 relative à la publicité des participations importantes (« loi transparence »), à la suite d’une notification re...

1h / 27m 1 EN
 PRESS RELEASE
Free
IBAB Ion Beam Applic...

IBA – Regulated information

IBA – Regulated information                                                                                                                   November 7th, 2025 Publication made under article 15 of the law of May 2, 2007 relating to the disclosure of major holdings in issuers whose shares are admitted to trading on a regulated market and containing various provisions (Belgian Gazette 12.VI.2007) (hereinafter, the “Law”). Under this provision:  « [...] the issuer publishes the total capital, the total number of securities conferring the right to vote and voting rights, as well as, by cate...

November 7, 2025 1 EN
 PRESS RELEASE
Free
IBAB Ion Beam Applic...

IBA – Information Réglementée

IBA – Information Réglementée 7 novembre 2025 Publication effectuée en vertu de l’article 15 de la loi du 2 mai 2007 relative à la publicité des participations importantes dans des émetteurs dont les actions sont admises à la négociation sur un marché réglementé et portant des dispositions diverses (M.B. 12.VI.2007) (ci-après, la « Loi »). En vertu de cette disposition : « [...] l'émetteur publie le total du capital, le nombre total de titres conférant le droit de vote et de droits de vote, ainsi que, par catégorie, le nombre de titres conférant le droit de vote et de droits de vote, au ...

November 7, 2025 1 EN
 PRESS RELEASE
Free
IBAB Ion Beam Applic...

IBA integrates Artificial Intelligence Quality Assurance into dosimetr...

IBA integrates Artificial Intelligence Quality Assurance into dosimetry solutions through the acquisition of PhantomX GmbH Dosimetry portfolio strengthened with Medical Imaging QA and AI validation  Louvain-la-Neuve, Belgium, 03 November 2025 - IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and a world-leading provider of quality assurance (QA) solutions, today announces the acquisition of PhantomX GmbH, expanding IBA’s portfolio in healthcare diagnostics and therapeutic systems enabling artificial intelligence (AI) quality assurance. Found...

November 3, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch